FDA-cleared profile

CT 5300

Philips Healthcare (Suzhou) Co., Ltd.

CT 5300 acquires head and whole-body cross-sectional CT images for diagnosis and supports low-dose lung-cancer screening under approved protocols in adult and pediatric patients.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
CT 5300 acquires head and whole-body cross-sectional CT images for diagnosis and supports low-dose lung-cancer screening under approved protocols in adult and pediatric patients.
FDA source Exact FDA submission Checked 2026-09-03
Intended users
Qualified CT technologists and physicians trained in diagnostic CT and protocol selection.
FDA source Exact FDA submission Checked 2026-09-03
Care setting and population
Hospital and outpatient diagnostic CT departments.
FDA source Exact FDA submission Checked 2026-09-03
Workflow role
Diagnostic CT acquisition, reconstruction, review, and protocol-governed low-dose lung-cancer screening.
Public source Exact FDA submission Checked 2026-09-03
Required input
X-ray projection data acquired with patient- and indication-appropriate CT protocols.
FDA source Exact FDA submission Checked 2026-09-03
Output and human action
Cross-sectional CT images and associated dose and examination information.
FDA source Exact FDA submission Checked 2026-09-03
Limitations
Vendor image-quality and dose claims are based on stated phantom comparisons and are not guaranteed patient outcomes. Verify pediatric protocols, lung-screening eligibility, dose monitoring, cardiac options, and installed software.
FDA source Exact FDA submission Checked 2026-09-03

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K232491
FDA source Exact FDA submission Checked 2026-08-31
Modality
CT/CTA
FDA source Exact FDA submission Checked 2026-09-03
Anatomy
Multi-region
FDA source Exact FDA submission Checked 2026-09-03
Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2024-05-03
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
DICOM and IHE integration is documented for current Philips CT products; test exact software, worklist, PACS, dose-report, reconstruction, and advanced-object interoperability.
Public source Exact FDA submission Checked 2026-09-03
Deployment and data flow
Installed CT scanner with model-specific gantry, table, console, reconstruction hardware, networking, shielding, power, cooling, and service requirements.
Public source Exact FDA submission Checked 2026-09-03
Security and privacy
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-03

Public materials reviewed for this batch do not establish the complete security posture for the exact release. Request data-flow, identity, audit, encryption, retention, support-access, vulnerability-management, backup, and incident-response evidence.

Training and support
Only qualified ct technologists and physicians trained in diagnostic ct and protocol selection. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
FDA source Exact FDA submission Checked 2026-09-03
Monitoring and change control
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Vendor image-quality and dose claims are based on stated phantom comparisons and are not guaranteed patient outcomes. Verify pediatric protocols, lung-screening eligibility, dose monitoring, cardiac options, and installed software.
Public source Exact FDA submission Checked 2026-09-03

Release and scope verification

Map the installed model, build, options, population, anatomy, inputs, and outputs to K232491 before acceptance.

exact submission · checked 2026-09-03

Later product-family features are not evidence that this cleared release includes them.

Interoperability acceptance

DICOM and IHE integration is documented for current Philips CT products; test exact software, worklist, PACS, dose-report, reconstruction, and advanced-object interoperability.

exact submission · checked 2026-09-03

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Vendor image-quality and dose claims are based on stated phantom comparisons and are not guaranteed patient outcomes. Verify pediatric protocols, lung-screening eligibility, dose monitoring, cardiac options, and installed software.

exact submission · checked 2026-09-03

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-03

Vendor productivity claims are scenario inputs, not guaranteed local savings.

Lifecycle monitoring

Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Vendor image-quality and dose claims are based on stated phantom comparisons and are not guaranteed patient outcomes. Verify pediatric protocols, lung-screening eligibility, dose monitoring, cardiac options, and installed software.

exact submission · checked 2026-09-03

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
K232491 describes manufacturer electrical, radiation, image-quality, dose, software, and system validation. Current vendor phantom claims provide evaluation inputs but should retain their reconstruction, dose, and object-size conditions.
Public source Exact FDA submission Checked 2026-09-03
Reported sensitivity
Not applicable
Not applicable Not applicable Checked 2026-09-03

Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or dose-delivery function. Use the task-specific endpoints and tested population reported below.

Reported specificity
Not applicable
Not applicable Not applicable Checked 2026-09-03

Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or dose-delivery function. Use the task-specific endpoints and tested population reported below.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K232491 FDA performance package for CT 5300

Manufacturer bench, phantom, image-quality, dose, software, electrical-safety, and system verification · Representative adult and pediatric head and body CT protocols, including approved low-dose lung screening

exact submission · Tested version: CT 5300 cleared in K232491 · Sponsor or vendor study

K232491

Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-03

No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

Reimbursement and coding
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the device within the applicable imaging or surgical service line and verify payer, site-of-service, and coding assumptions independently.
Public source Not applicable Checked 2026-09-03

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

Build a local total-cost and value model; do not infer reimbursement from FDA clearance.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
2 reviewed FDA recall records in the 2026-09-02 openFDA snapshot natively identify K232491. Read the model- and version-scoped events and confirm affected-unit and correction status with the manufacturer. FDA recall Z-0376-2026 affects CT 5300 software 5.1.0.X and 5.1.1.X and describes six motion, dose-setting, ECG-file, orientation, preview-display, and manual-ROI issues that could produce unusable imaging, additional exposure, or rescanning. FDA lists the recall as open and classified. FDA recall Z-0882-2026 affects CT 5300 software versions 4.5, 5.0, and 5.1 because improperly tightened heat-exchanger screws after replacement could allow a component to detach inside the rotating scanner. FDA lists the recall as open and classified.
FDA source Exact product version Checked 2026-09-04

Each published event was manually matched to the exact FDA submission and affected product or version; a recall does not establish an AI-algorithm defect or current site exposure unless the event states that scope.

recall: Z-0376-2026

Open, Classified

2025-10-27

Exact CT 5300 model and software-version match. Review the full FDA event, installed version, field correction, and local exposure to each of the six conditions.

recall: Z-0882-2026

Open, Classified

2025-12-03

Exact CT 5300 model and software-version match. Confirm whether the tube heat exchanger was replaced and whether the inspection or correction was completed.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
24Fields reviewed
8Source classes checked
0Unreviewed PubMed leads
5Unreviewed trial leads
0Unreviewed FDA recall leads

Recovered from the prior exact-submission extraction and normalized under the current provenance rules. Exact FDA materials, current product-family sources, selected clinical literature, reimbursement context, and exact-identifier recall candidates were reviewed. Pricing, contracted services, enabled options, final security architecture, and local interoperability remain organization-specific evidence. Automated exact-name discovery found 0 PubMed and 5 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. 5 FDA recall candidates were manually reviewed: 2 published and 3 rejected as a neighboring or otherwise inapplicable version. Native FDA recall identifiers produced 5 postmarket candidate records; 5 have been reviewed (2 published, 3 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, fda decision summary, vendor product page, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-04.

Alternatives

Related tools to compare

FDA-cleared K253649

Spectral CT Verida Family

Philips Medical Systems Technologies, Ltd.

Spectral CT Verida Family supports the labeled spectral CT acquisition, reconstruction, material-map, and professional-interpretation workflow; exact models, protocols, and...

Modality
CT/CTA
Anatomy
Multi-region
Decision
2026-03-27
FDA-cleared K253574

SOMATOM X.cite; SOMATOM X.ceed

Siemens Medical Solutions USA, Inc.

SOMATOM X.cite and X.ceed with syngo CT VB20 support diagnostic CT, interventions, treatment preparation, radiation-therapy planning, and qualified low-dose lung screening.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2026-03-20
FDA-cleared K233657

NAEOTOM Alpha

Siemens Medical Solutions USA, Inc.

NAEOTOM Alpha with syngo CT VB10 provides photon-counting CT for diagnosis, treatment and interventional support, and approved low-dose lung screening; this submission explicitly...

Modality
CT/CTA
Anatomy
Multi-region
Decision
2024-03-28